Watchful Waiting for Complete Responders to Therapy in Rectal Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Rectal Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Ascension St. John Hospital, Detroit, Michigan, United States
Contact: Study coordinator (Amr Aref, MD) · amr.aref@ascension.org · 313-647-3100
Contact: Study coordinator (Karen Forman) · karen.forman@ascension.org · 313-343-4974

Study leads

Amr Aref, MD
Principal Investigator
Ascension St. John Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Diffuse Astrocytoma, IDH-Mutant · Glioblastoma, IDH-wildtype · Brain Metastases, Adult

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beverly Hills, United States · Glendale, United States

Total Neoadjuvant Therapy With mFOLFOX and Short-course Radiation in Resectable Rectal Cancer

Rectal Cancer

Abroad (travel likely)RecruitingPHASE2

Richmond, United States · Richmond, United States

A Phase II Study of Pirfenidone Plus PD-1 Inhibitor With or Without Hypofractionated Radiotherapy for Refractory pMMR/MSS Colorectal Cancer

Colorectal Cancer (CRC)

Abroad (travel likely)RecruitingPHASE2

Wuhan, China

A Phase II Randomized Trial of Serplulimab With Second-Line Chemo/Targeted Therapy for Early Relapse Colorectal Cancer After Adjuvant Chemotherapy

Colorectal Cancer · Relapse

Abroad (travel likely)RecruitingPHASE2

Shanghai, China